Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does BLEOMYCIN Cause Therapy partial responder? 52 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 52 reports of Therapy partial responder have been filed in association with BLEOMYCIN (Bleomycin). This represents 0.8% of all adverse event reports for BLEOMYCIN.

52
Reports of Therapy partial responder with BLEOMYCIN
0.8%
of all BLEOMYCIN reports
3
Deaths
4
Hospitalizations

How Dangerous Is Therapy partial responder From BLEOMYCIN?

Of the 52 reports, 3 (5.8%) resulted in death, 4 (7.7%) required hospitalization, and 2 (3.8%) were considered life-threatening.

Is Therapy partial responder Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for BLEOMYCIN. However, 52 reports have been filed with the FAERS database.

What Other Side Effects Does BLEOMYCIN Cause?

Off label use (656) Febrile neutropenia (632) Neutropenia (433) Drug ineffective (395) Pyrexia (291) Product use in unapproved indication (280) Pulmonary toxicity (263) Thrombocytopenia (260) Nausea (255) Anaemia (252)

What Other Drugs Cause Therapy partial responder?

CYCLOPHOSPHAMIDE (1,397) RITUXIMAB (1,219) DEXAMETHASONE (1,199) PREDNISONE (1,176) PEMBROLIZUMAB (1,125) CARBOPLATIN (1,096) DOXORUBICIN (834) METHOTREXATE (775) VINCRISTINE (707) ETOPOSIDE (670)

Which BLEOMYCIN Alternatives Have Lower Therapy partial responder Risk?

BLEOMYCIN vs BLINATUMOMAB BLEOMYCIN vs BLONANSERIN BLEOMYCIN vs --BLOOD-COAGULATION FACTOR VIII FUSION PROTEIN WITH IMMUNOGLOBULIN G1 , ,-BIS WITH IMMUNOGLOBULIN G1 BLEOMYCIN vs BOCEPREVIR BLEOMYCIN vs BOCOCIZUMAB

Related Pages

BLEOMYCIN Full Profile All Therapy partial responder Reports All Drugs Causing Therapy partial responder BLEOMYCIN Demographics